Citations: Schuster-Kolbe,J.; Ludwig,H.; Adolf,G.R.; Heider,K.H.. Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19+ B cells of patients with multiple myeloma and healthy individuals. Leuk.Lymphoma 1999;34:95-103. (Link)
Saegusa,Makoto; Okayasu,Isao. Up-regulation of CD44 Variant Exon Expression in Endometrial Carcinomas: Analysis of mRNA and Protein Isoforms, and Relation to Clinicopathological Factors. Cancer Science 1998;89:291-298. (Link)
Van Hal,Nicole L.W.; van Dongen,Guus A.M.S.; Ten Brink,Corlinda B.M.; Heider,Karl Heinz; Rech-Weichselbraun,Irene; Snow,Gordon B.; Brakenhoff,Ruud H.. Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 1999;5:3534-3541. (Link)
Sconocchia,G.; Titus,J.A.; Segal,D.M.. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. The Journal of Immunology 1994;153:5473-5481. (Link)
Hoffmann,U.; Heilmann,K.; Hayford,C.; Stallmach,A.; Wahnschaffe,U.; Zeitz,M.; Gunthert,U.; Wittig,B.. CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ 2007;(Link)
CHUANG,C.K.; SHEN,Y.C.; WU,J.H.; TSAI,L.H.; LIAO,S.K.. IMMUNOBIOLOGIC, CYTOGENETIC AND DRUG RESPONSE FEATURES OF A NEWLY ESTABLISHED CELL LINE (SCRC-1) FROM RENAL SMALL CELL... The Journal of urology 2000;163:1016-1021. (Link)
Rodriguez-Rodriguez,L.; Sancho-Torres,I.; Gibbon,D.G.; Miller Watelet,L.F.; Mesonero,C.. CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva. Journal of the Society for Gynecologic Investigation 2000;7:70-75. (Link)
Stauder,R.; Van Driel,M.; Schwarzler,C.; Thaler,J.; Lokhorst,H.M.; Kreuser,E.D.; Bloem,A.C.; Gunthert,U.; Eisterer,W.. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996;88:3101-3108. (Link)
